Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B

Schwarz, K., Bezerra, J., Choe, B.-H., Lin, C.-H., Abramov, F., Nguyen, A.-H., Liu, Y., Leisegang, R., Flaherty, J., Pacurar, D., Kim, K. M., Khaertynova, I., Shalimar, Wu, J.-F., Tandon, M., Rosenthal, P., Viacheslav, M., Sokal, E., & Chang, M.-H. (2022). Randomized, double-blind, placebo-controlled trial of Tenofovir Alafenamide in children and adolescents with chronic hepatitis B. International Liver Congress (EASL), Londres, Angleterre. https://hdl.handle.net/2078.5/101432